Lisa A. Marsch, Director Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth, Dartmouth College (USA)
Host: Michael Krauthammer (UZH)
Abstract:
Dr. Marsch will describe the development and a couple of decades of research focused on the development and rigorous testing of clinically validated, digital therapeutics for substance use disorders and behavioral health. She will give examples of how healthcare can be transformed to deliver scalable, science-based behavioral health care via digital health approaches. And she will share the journey of scaling up the most empirically-supported digital treatment for substance use disorders to become the very first “prescription digital therapeutic” authorized by the U.S. Food and Drug Administration, which can be prescribed in the U.S. (and increasingly in other countries). She will discuss opportunities to leverage digital health measurement (e.g., digital phenotyping) to enhance the personalization of digital therapeutics and highlight the trans-diagnostic utility of digital health approaches.